Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6879499 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL2332737 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL28916786 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL3731166 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL5970293 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL28706062 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL11668063 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL28727667 | 0.98 | ACE2 (0.44) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL6569983 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL2569847 | 0.98 | ACE2 (0.48) | ACE2GPR84CA1FFAR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007042410-A1 | DEODORIZING CLEANSING PREPARATION | BEIERSDORF AG (DE) | 2007-04-19 | — | — | WO | claimed |
| US-6514458-B1 | Anionic surfactant comprising an alkyl substituted carboxylic acid and a polyoxyethylene-polyoxypropylene block copolymer; disinfecting | GE BETZ, INC. | 2003-02-04 | — | — | US | claimed |
| EP-1259111-A1 | METHOD FOR REMOVING MICROBIAL BIOFILMS FROM SURFACES | BetzDearborn Inc (US) | 2002-11-27 | — | — | EP | claimed |
| EP-1259115-A1 | METHOD FOR ENHANCING BIOCIDAL ACTIVITY | BetzDearborn Inc (US) | 2002-11-27 | — | — | EP | claimed |
| WO-2001062084-A1 | METHOD FOR REMOVING MICROBIAL BIOFILMS FROM SURFACES | BETZDEARBORN INC. (US) | 2001-08-30 | — | — | WO | claimed |
| WO-2001062091-A1 | METHOD FOR ENHANCING BIOCIDAL ACTIVITY | BETZDEARBORN INC. (US) | 2001-08-30 | — | — | WO | claimed |
| US-20240130994-A1 | IONIC LIQUID FORMULATIONS FOR TREATING DIABETES | I2O THERAPEUTICS, INC. | 2024-04-25 | — | — | US | disclosed |
| US-20150210660-A1 | ALICYCLIC EPOXY COMPOUND AND METHOD FOR PRODUCING SAME | DAICEL CORPORATION (JP) | 2015-07-30 | — | — | US | disclosed |
| EP-2891652-A1 | ALICYCLIC EPOXY COMPOUND AND METHOD FOR PRODUCING SAME | Daicel Corporation (JP) | 2015-07-08 | — | — | EP | disclosed |
| EP-1761618-A1 | USE OF A MIXTURE OF CIS- AND TRANS-3-METHYL-G-DECALACTONE AND COMPOSITIONS OF ODORIFEROUS SUBSTANCES AND PERFUMED ARTICLES COMPRISING SAID MIXTURE | Symrise GmbH & Co. KG (DE) | 2007-03-14 | — | — | EP | disclosed |
| WO-2005123889-A1 | USE OF A MIXTURE OF CIS- AND TRANS-3-METHYL-G-DECALACTONE AND COMPOSITIONS OF ODORIFEROUS SUBSTANCES AND PERFUMED ARTICLES COMPRISING SAID MIXTURE | SYMRISE GMBH & CO. KG (DE) | 2005-12-29 | — | — | WO | disclosed |
| WO-2005012222-A1 | ALICYCLIC ESTER WITH MUSK FRAGRANCE | SYMRISE GMBH & CO. KG (DE) | 2005-02-10 | — | — | WO | disclosed |
| US-6514458-B1 | Anionic surfactant comprising an alkyl substituted carboxylic acid and a polyoxyethylene-polyoxypropylene block copolymer; disinfecting | GE BETZ, INC. | 2003-02-04 | — | — | US | disclosed |
| EP-1259111-A1 | METHOD FOR REMOVING MICROBIAL BIOFILMS FROM SURFACES | BetzDearborn Inc (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1259115-A1 | METHOD FOR ENHANCING BIOCIDAL ACTIVITY | BetzDearborn Inc (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1192125-A2 | MONO- AND DISUBSTITUTED 3-PROPYL GAMMA-AMINOBUTYRIC ACIDS | WARNER-LAMBERT COMPANY (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2001062084-A1 | METHOD FOR REMOVING MICROBIAL BIOFILMS FROM SURFACES | BETZDEARBORN INC. (US) | 2001-08-30 | — | — | WO | disclosed |
| WO-2001062091-A1 | METHOD FOR ENHANCING BIOCIDAL ACTIVITY | BETZDEARBORN INC. (US) | 2001-08-30 | — | — | WO | disclosed |
| WO-2000076958-A2 | MONO- AND DISUBSTITUTED 3-PROPYL GAMMA-AMINOBUTYRIC ACIDS | WARNER-LAMBERT COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240130994-A1 | IONIC LIQUID FORMULATIONS FOR TREATING DIABETES | GPR119, FABP4, PNLIP | ACE2 2974/4885GPR84 1817/4885CA1 4827/4885 |
| US-20150210660-A1 | ALICYCLIC EPOXY COMPOUND AND METHOD FOR PRODUCING SAME | OXER1, ALOX12, AKR1C1 | ACE2 1614/4885GPR84 342/4885CA1 517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.